Physician

Kendall Whitfield Wannamaker, M.D.

According to 2025 Medicare claims, Kendall Wannamaker, M.D. (NPI: 1962882886) practices ophthalmology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is CAROLINA EYE ASSOCIATES INC (NPI: 1245211333; TIN: 56-1183309) and primary practice location at 28387-2927.

Wannamaker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 854 traditional Medicare patients, billed 103,030 HCPCS/CPT codes, and received $3,436,083 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 691 prescription claims across 244 beneficiaries totaling $37,624 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 23 records totaling $839. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $41,210 to $3,436,083. Similarly, Part D prescription costs have risen steadily, from $323 to $37,624. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2019 Medicare payment: $41,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $66,351 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $767,830 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,339,582 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,712,489 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,436,083 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019172390$41,210
2020234483$66,351
20215604,159$767,830
202292014,544$2,339,582
202393237,769$2,712,489
2024854103,030$3,436,083

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$41K2015 Drug cost: $323 (USD; Tot_Drug_Cst)2016 Drug cost: $5,746 (USD; Tot_Drug_Cst)2017 Drug cost: $753 (USD; Tot_Drug_Cst)2018 Drug cost: $1,997 (USD; Tot_Drug_Cst)2019 Drug cost: $2,722 (USD; Tot_Drug_Cst)2020 Drug cost: $3,916 (USD; Tot_Drug_Cst)2021 Drug cost: $12,509 (USD; Tot_Drug_Cst)2022 Drug cost: $36,807 (USD; Tot_Drug_Cst)2023 Drug cost: $40,948 (USD; Tot_Drug_Cst)2024 Drug cost: $37,624 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R11$323
201622153$5,746
2017N/R28$753
2018N/R25$1,997
20191831$2,722
20202869$3,916
202189195$12,509
2022212651$36,807
2023249627$40,948
2024244691$37,624

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more429544$86
67028Injection of drug into eye3801,607$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more218253$55
92134Imaging of retina7842,322$28
J2777Injection, faricimab-svoa, 0.1 mg32296,240$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost231,082$10,114
Prednisolone AcetatePrednisolone Acetate1996,997$9,963
CombiganBrimonidine Tartrate/Timolol17725$4,176
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol16730$2,881
Brimonidine TartrateBrimonidine Tartrate764,214$2,162

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$839Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kendall Whitfield Wannamaker, M.D.?

Tedicare shows public-source Medicare data for Kendall Whitfield Wannamaker, M.D. (NPI 1962882886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kendall Whitfield Wannamaker, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kendall Whitfield Wannamaker, M.D.?

Kendall Whitfield Wannamaker, M.D. is linked to CAROLINA EYE ASSOCIATES INC (billing NPI 1245211333) in the available physician profile data.

Does Kendall Whitfield Wannamaker, M.D. have Open Payments data?

Kendall Whitfield Wannamaker, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.